Source: FinanzNachrichten

Rappta: Evotec Partners With Rappta To Focus On Oncology Target

HAMBURG (dpa-AFX) - Evotec SE (EVTCY.PK, EVOTF.PK) said that it has entered into discovery and development partnership with a Finland-based biopharmaceutical company, Rappta Therapeutics, to focus...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Sunjeet Sawhney's photo - CEO of Rappta

CEO

Sunjeet Sawhney

CEO Approval Rating

90/100

Read more